CompletedNot Applicable

Relapse Among Diabetic Ketoacidosis Patients Maintained Basal Bolus Insulin Administration in Combination With Continuous Intravenous Insulin Infusion VS Non Maintaining Basal Insulin Patients

Egypt100 participantsStarted 2023-11-30

Plain-language summary

This study aimed to assess intensive care unit stay and relapse among patients of Diabetic ketoacidosis (type 1 diabetes mellitus) maintained basal bolus insulin and patients non maintaining along with intervenors insulin infusion.

Who can participate

Age range21 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients aged 21y or more * who are known to have type 1 diabetes on known basal bolus insulin regimen - presented with diabetic ketoacidosis. Exclusion Criteria: * Patients with type 2 diabetes mellitus. * If hemodynamically unstable patients. * Patients with other metabolic problems (hepatic coma, renal failure, disturbed conscious level .

What they're measuring

Resolution of diabetic ketoacidosis

Timeframe: 4 days

Trial details

NCT IDNCT07423559

SponsorTanta University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-30

View on ClinicalTrials.gov More Diabetic Ketoacidosis trials